Poland· PL-100494330
Candepres HCT
A candesartan und diuretika product containing candesartanum cilexetili + hydrochlorothiazidum, registered in Poland by Medezin Sp. z o.o.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Candesartan und diuretika is registered in 12 of 19 countries.
Countries holding a registration under ATC C09DA06 (candesartan und diuretika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Candesartan und diuretika · ATC C09DA06
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Candesartanum cilexetili + Hydrochlorothiazidum
- Manufacturer
- Medezin Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- C09DA06
- ATC class
- Candesartan und Diuretika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909991533953
- gtin05909991533960
- gtin05909991533977
- gtin05909991533984
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for candesartan und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under C09DA06
Candesartan und diuretika, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f72d401c-32bb-4dc1-ac91-0509d94e3f1d GET /v1/drugs/f72d401c-32bb-4dc1-ac91-0509d94e3f1d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "16 mg + 12,5 mg",
"packaging": "05909991533953 ¦ Rp ¦ 153586\n30 tabl.\n05909991533960 ¦ Rp ¦ 153587\n56 tabl.\n05909991533977 ¦ Rp ¦ 153588\n60 tabl.\n05909991533984 ¦ Rp ¦ 153589\n28 tabl.",
"substance": "Candesartanum cilexetili 16 mg + Hydrochlorothiazidum 12.5 mg",
"common_name": "Candesartanum cilexetili + Hydrochlorothiazidum",
"pl_product_id": "100494330",
"pozwolenie_nr": "100/24",
"auth_procedure": "IR",
"authorisation_validity": "2029-03-13"
}See everything about candesartan und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.